Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 26 May 1978:
Vol. 200. no. 4344, pp. 871 - 873
DOI: 10.1126/science.644328
Prev | Table of Contents | Next

Articles

Science, Vol 200, Issue 4344, 871-873
Copyright © 1978 by American Association for the Advancement of Science

articles

The development and regulation of new medications

L Lasagna

The unmet needs of many patients make the successful search for new and better drugs an urgent goal. Increasing regulatory demands have generated delays in the availability of new drugs and concerns about the long-term profitability of the innovative pharmaceutical industry. A rational and flexible approach to drug regulation could ease some of the most worrisome constraints without jeopardizing the public welfare. Changes in our national drug regulatory policy and in the performance of the Food and Drug Administration will serve our society better than drastic legislative mandates intended either to emasculate the FDA or to grant the agency broad new powers.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Prescribing Approved Drugs for Nonapproved Uses: Physicians' Disclosure Obligations to Their Patients.
M. B. Kapp (1981)
J. Law Med. Ethics 9, 20-23
   PDF »
Evaluation of medical practices.
H. Frazier and H. Hiatt (1978)
Science 200, 875-878
   Abstract »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)